{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:50:31Z","timestamp":1789426231347,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02032-4","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T11:44:55Z","timestamp":1676288695000},"page":"1799-1806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Familial parathyroid tumours\u2014comparison of clinical profiles between syndromes"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1686-0163","authenticated-orcid":false,"given":"A. A.","family":"Figueiredo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Saramago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M.","family":"Cavaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sim\u00f5es-Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"2032_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.623667","volume":"12","author":"JE Blau","year":"2021","unstructured":"Blau JE, Simonds WF (2021) Familial hyperparathyroidism. Front Endocrinol (Lausanne) 12:1\u201314. https:\/\/doi.org\/10.3389\/fendo.2021.623667","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2032_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12672-020-00394-2","volume":"11","author":"S Khairi","year":"2020","unstructured":"Khairi S, Osborne J, Jacobs MF et al (2020) Outcome of clinical genetic testing in patients with features suggestive for hereditary predisposition to PTH-mediated hypercalcemia. Horm Cancer 11:250\u2013255. https:\/\/doi.org\/10.1007\/s12672-020-00394-2","journal-title":"Horm Cancer"},{"key":"2032_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.beem.2018.09.010","volume":"32","author":"C Eller-Vainicher","year":"2018","unstructured":"Eller-Vainicher C, Falchetti A (2018) Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32:861\u2013875. https:\/\/doi.org\/10.1016\/j.beem.2018.09.010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2032_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/cen.14254","volume":"93","author":"S Mariathasan","year":"2020","unstructured":"Mariathasan S, Andrews KA, Thompson E et al (2020) Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort. Clin Endocrinol (Oxf) 93:409\u2013418. https:\/\/doi.org\/10.1111\/cen.14254","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2032_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joim.12523","volume":"280","author":"RV Thakker","year":"2016","unstructured":"Thakker RV (2016) Genetics of parathyroid tumours. J Intern Med 280:574\u2013583. https:\/\/doi.org\/10.1111\/joim.12523","journal-title":"J Intern Med"},{"key":"2032_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1530\/EC-17-0126","volume":"6","author":"E Mamedova","year":"2017","unstructured":"Mamedova E, Mokrysheva N, Vasilyev E et al (2017) Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome. Endocr Connect 6:557\u2013565. https:\/\/doi.org\/10.1530\/EC-17-0126","journal-title":"Endocr Connect"},{"key":"2032_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","volume":"400","author":"M Iacobone","year":"2015","unstructured":"Iacobone M, Carnaille B, Palazzo FF, Vriens M (2015) Hereditary hyperparathyroidism\u2014a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck\u2019s Arch Surg 400:867\u2013886. https:\/\/doi.org\/10.1007\/s00423-015-1342-7","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"2032_CR8","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1210\/jc.2013-1204","volume":"98","author":"SA Wells","year":"2013","unstructured":"Wells SA, Pacini F, Robinson BG, Santoro M (2013) Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab 98:3149\u20133164. https:\/\/doi.org\/10.1210\/jc.2013-1204","journal-title":"J Clin Endocrinol Metab"},{"key":"2032_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2018.00533","volume":"9","author":"JM De Laat","year":"2018","unstructured":"De Laat JM, Van Leeuwaarde RS, Valk GD (2018) The importance of an early and accurate MEN1 diagnosis. Front Endocrinol (Lausanne) 9:1\u20138. https:\/\/doi.org\/10.3389\/fendo.2018.00533","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2032_CR10","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230","journal-title":"J Clin Endocrinol Metab"},{"key":"2032_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1365-2265.2002.01505.x","volume":"56","author":"BM Cavaco","year":"2002","unstructured":"Cavaco BM, Domingues R, Bacelar MC et al (2002) Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clin Endocrinol (Oxf) 56:465\u2013473. https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01505.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2032_CR12","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1210\/jc.2003-031016","volume":"89","author":"BM Cavaco","year":"2004","unstructured":"Cavaco BM, Guerra L, Bradley KJ et al (2004) Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab 89:1747\u20131752. https:\/\/doi.org\/10.1210\/jc.2003-031016","journal-title":"J Clin Endocrinol Metab"},{"key":"2032_CR13","doi-asserted-by":"publisher","first-page":"e28145","DOI":"10.1097\/MD.0000000000028145","volume":"100","author":"C Chaves","year":"2021","unstructured":"Chaves C, Nunes da Silva T, Dias Pereira B et al (2021) A case report of multiple endocrine neoplasia type 1 and autoimmune disease: coincidence or correlation? Medicine (Baltimore) 100:e28145. https:\/\/doi.org\/10.1097\/MD.0000000000028145","journal-title":"Medicine (Baltimore)"},{"key":"2032_CR14","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jamcollsurg.2018.01.007","volume":"226","author":"M El Lakis","year":"2018","unstructured":"El Lakis M, Nockel P, Gaitanidis A et al (2018) Probability of positive genetic testing results in patients with family history of primary hyperparathyroidism. J Am Coll Surg 226:933\u2013938. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2018.01.007","journal-title":"J Am Coll Surg"},{"key":"2032_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","volume":"17","author":"A Al-Salameh","year":"2021","unstructured":"Al-Salameh A, Cadiot G, Calender A et al (2021) Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol 17:207\u2013224. https:\/\/doi.org\/10.1038\/s41574-021-00468-3","journal-title":"Nat Rev Endocrinol"},{"key":"2032_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1055\/s-0043-120670","volume":"49","author":"SJ Marx","year":"2017","unstructured":"Marx SJ, Lourenco DM (2017) Familial hyperparathyroidism\u2014disorders of growth and secretion in hormone-secretory tissue. Horm Metab Res 49:805\u2013815. https:\/\/doi.org\/10.1055\/s-0043-120670","journal-title":"Horm Metab Res"},{"key":"2032_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.lpm.2018.03.005","volume":"47","author":"A Al-Salameh","year":"2018","unstructured":"Al-Salameh A, Baudry C, Cohen R (2018) Update on multiple endocrine neoplasia type 1 and 2. Press Medicale 47:722\u2013731. https:\/\/doi.org\/10.1016\/j.lpm.2018.03.005","journal-title":"Press Medicale"},{"key":"2032_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000491037","volume":"51","author":"F Cetani","year":"2018","unstructured":"Cetani F, Saponaro F, Borsari S, Marcocci C (2018) Familial and hereditary forms of primary hyperparathyroidism. Front Horm Res 51:40\u201351. https:\/\/doi.org\/10.1159\/000491037","journal-title":"Front Horm Res"},{"key":"2032_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-3-319-22542-5_8","volume":"204","author":"M Alevizaki","year":"2015","unstructured":"Alevizaki M, Saltiki K (2015) Primary hyperparathyroidism in MEN2 syndromes. Recent Results Cancer Res 204:179\u2013186. https:\/\/doi.org\/10.1007\/978-3-319-22542-5_8","journal-title":"Recent Results Cancer Res"},{"key":"2032_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1761030","author":"F Torresan","year":"2019","unstructured":"Torresan F, Iacobone M (2019) Clinical features, treatment, and surveillance of hyperparathyroidism-jaw tumor syndrome: an up-to-date and review of the literature. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2019\/1761030","journal-title":"Int J Endocrinol"},{"key":"2032_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/9781119266594.ch83","volume":"1","author":"A Arnold","year":"2018","unstructured":"Arnold A, Agarwal SK, Thakker RV (2018) Familial states of primary hyperparathyroidism. Prim Metab Bone Dis Disord Miner Metab 1:629\u2013638. https:\/\/doi.org\/10.1002\/9781119266594.ch83","journal-title":"Prim Metab Bone Dis Disord Miner Metab"},{"key":"2032_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00268-019-05156-y","volume":"44","author":"M Iacobone","year":"2020","unstructured":"Iacobone M, Camozzi V, Mian C et al (2020) Long-term outcomes of parathyroidectomy in hyperparathyroidism-jaw tumor syndrome: analysis of five families with CDC73 mutations. World J Surg 44:508\u2013516. https:\/\/doi.org\/10.1007\/s00268-019-05156-y","journal-title":"World J Surg"},{"key":"2032_CR23","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1210\/jcem.86.2.7220","volume":"86","author":"D Zehnder","year":"2001","unstructured":"Zehnder D, Bland R, Williams MC et al (2001) Extrarenal expression of 25-hydroxyvitamin D 3\u20131\u03b1-hydroxylase 1. J Clin Endocrinol Metab 86:888\u2013894. https:\/\/doi.org\/10.1210\/jcem.86.2.7220","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02032-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02032-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T14:57:11Z","timestamp":1690383431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02032-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2032"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02032-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"17 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local Ethics Committee of Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived because of the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}